Bluebird bio Inc Cash Flow-to-Debt Ratio
Bluebird bio Inc cash flow-to-debt ratio. Bluebird bio Inc (BLUE) has a Cash Flow-to-Debt Ratio of -0.12x as of March 2025, meaning its operating cash flow of $-43.44 Million could theoretically repay 0% of its total liabilities ($353.82 Million) in one year. Check how high is Bluebird bio Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Bluebird bio Inc (2011–2024)
Cash flow-to-debt ratio of Bluebird bio Inc from 2011 to 2024. Historical debt coverage capacity for Bluebird bio Inc across 14 annual periods. Check BLUE cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Bluebird bio Inc Cash Flow-to-Debt Ratio by Year (2011–2024)
Bluebird bio Inc cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Bluebird bio Inc. For the full cash flow conversion analysis, see Bluebird bio Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.53x | $-260.02 Million | $491.77 Million | ▲ +4.5% |
| 2023 | -0.55x | $-235.05 Million | $424.62 Million | ▲ +43.8% |
| 2022 | -0.98x | $-352.95 Million | $358.56 Million | ▲ +66.0% |
| 2021 | -2.90x | $-635.64 Million | $219.52 Million | ▼ -162.4% |
| 2020 | -1.10x | $-470.35 Million | $426.20 Million | ▲ +13.5% |
| 2019 | -1.28x | $-564.38 Million | $442.43 Million | ▼ -10.4% |
| 2018 | -1.16x | $-413.43 Million | $357.77 Million | ▼ -14.1% |
| 2017 | -1.01x | $-280.55 Million | $277.13 Million | ▼ -32.7% |
| 2016 | -0.76x | $-189.65 Million | $248.68 Million | ▼ -17.6% |
| 2015 | -0.65x | $-98.43 Million | $151.84 Million | ▲ +28.9% |
| 2014 | -0.91x | $-59.69 Million | $65.48 Million | ▼ -252.6% |
| 2013 | 0.60x | $43.45 Million | $72.72 Million | ▲ +455.1% |
| 2012 | -0.17x | $-21.04 Million | $125.07 Million | ▼ -19.3% |
| 2011 | -0.14x | $-12.22 Million | $86.62 Million | — |